Upgrade Alert for Sanofi-Aventis (SNY)
Sanofi-Aventis (NYSE:SNY) was upgraded from Equal Weight to Overweight at Barclays Capital today. The stock closed yesterday at $39.24 on volume of 2.0 million shares, below average daily volume of 2.4 million.
Sanofi-Aventis is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.
In the past 52 weeks, Sanofi-Aventis share prices have been bracketed by a low of $37.63 and a high of $54.98 and closed yesterday at $39.24, 4% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 0.6% while the 50-day MA has advanced 0.3%.
Sanofi-Aventis has overhead space with shares priced $39.24, or 28.7% below the average consensus analyst price target of $55.02. Sanofi-Aventis shares should first meet resistance at the 50-day moving average (MA) of $41.37 and find additional resistance at the 200-day MA of $45.02.
SmarTrend is monitoring the recent change of momentum in Sanofi-Aventis. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Sanofi-Aventis in search of a potential trend change.
Keywords: analyst upgrades/downgrades Sanofi-Aventis